The University of Chicago Header Logo

Connection

Walter M. Stadler to Matrix Metalloproteinase Inhibitors

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Matrix Metalloproteinase Inhibitors.
Walter M. Stadler
Connection Strength
0.068
Matrix Metalloproteinase Inhibitors
  1. A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases. Clin Cancer Res. 2006 Mar 01; 12(5):1556-63.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.